Literature DB >> 8091685

Mutational events in consecutive passages of hepatitis A virus strain GBM during cell culture adaptation.

J Graff1, C Kasang, A Normann, M Pfisterer-Hunt, S M Feinstone, B Flehmig.   

Abstract

In order to study the adaptation of hepatitis A virus (HAV) in cell culture, we examined the mutational events of the genome in early passages of HAV strain GBM propagated either in FRhK-4 cells (fetal rhesus monkey kidney-derived) or in human embryonic kidney (HEK) and human embryonic fibroblast cells (HFS) in relation to their growth characteristics. Sequence analysis of the nucleotide region encoding 2B, 2C, and the beginning of 3A as well as the nucleotide region encompassing the 5' noncoding region (5'NCR) of the genome was performed on consecutive virus passages after amplification of the viral RNA from the cell culture supernatant by antigen-capture PCR. By the 2nd passage of the GBM variants cultured in FRhK-4 or in HEK cells we found a mutation at nucleotide position 3889 (2B coding region) which results in an amino acid substitution from alanine to valine. Further mutations present in the 2B/2C region of the cell culture-adapted GBM variants differ from each other and occur after the 10th or even the 40th virus passage. Another early change, an in frame deletion of nine nucleotides in the 3A region, appeared in the 5th virus passage only in GBM cultured on FRhK-4 cells. This genome region showed different mutations in the virus passages on HEK and HFS cells. The 5'NCR of the cell culture-adapted GBM variants, in contrast, did not show any mutations before the 8th virus passage. The faster and more efficient growth of the HAV strain GBM during successive propagation on cell cultures seems to correlate with the appearance of mutations in the investigated genome regions.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8091685     DOI: 10.1006/viro.1994.1510

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  20 in total

1.  Mutational characteristics in consecutive passage of rapidly replicating variants of hepatitis A virus strain H2 during cell culture adaptation.

Authors:  Ning-Zhu Hu; Yun-Zhang Hu; Hai-Jing Shi; Guo-Dong Liu; Su Qu
Journal:  World J Gastroenterol       Date:  2002-10       Impact factor: 5.742

2.  Genetic characterization of a new pandemic Southeast Asia topotype strain of serotype O foot-and-mouth disease virus isolated in China during 2010.

Authors:  Haixue Zheng; Jijun He; Jianhong Guo; Ye Jin; Fan Yang; Lv Lv; Xiangtao Liu
Journal:  Virus Genes       Date:  2011-09-20       Impact factor: 2.332

3.  Improving proteolytic cleavage at the 3A/3B site of the hepatitis A virus polyprotein impairs processing and particle formation, and the impairment can be complemented in trans by 3AB and 3ABC.

Authors:  Y Kusov; V Gauss-Müller
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

Review 4.  Clinical development of a new inactivated hepatitis A vaccine.

Authors:  E Vidor; B Fritzell; S Plotkin
Journal:  Infection       Date:  1996 Nov-Dec       Impact factor: 3.553

5.  Emergence in Asia of foot-and-mouth disease viruses with altered host range: characterization of alterations in the 3A protein.

Authors:  N J Knowles; P R Davies; T Henry; V O'Donnell; J M Pacheco; P W Mason
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

6.  Genetic determinants of altered virulence of Taiwanese foot-and-mouth disease virus.

Authors:  C W Beard; P W Mason
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

7.  PCR-SSCP analysis of 5'-nontranslated region of hepatitis A viral RNA: comparison with clinicopathological features of hepatitis A.

Authors:  K Fujiwara; O Yokosuka; T Ehata; F Imazeki; H Saisho
Journal:  Dig Dis Sci       Date:  2000-12       Impact factor: 3.199

8.  Association between severity of type A hepatitis and nucleotide variations in the 5' non-translated region of hepatitis A virus RNA: strains from fulminant hepatitis have fewer nucleotide substitutions.

Authors:  K Fujiwara; O Yokosuka; T Ehata; H Saisho; N Saotome; K Suzuki; K Okita; K Kiyosawa; M Omata
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

9.  Molecular evolution of hepatitis A virus in a human diploid cell line.

Authors:  Cai-Hua Tang; Jiang-Sen Mao; Shao-Ai Chai; Yong Chen; Fang-Cheng Zhuang
Journal:  World J Gastroenterol       Date:  2007-09-14       Impact factor: 5.742

10.  Hepatitis A virus-encoded miRNAs attenuate the accumulation of viral genomic RNAs in infected cells.

Authors:  Jiandong Shi; Jing Sun; Meini Wu; Ningzhu Hu; Yunzhang Hu
Journal:  Virus Genes       Date:  2016-03-02       Impact factor: 2.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.